儿童急变期慢性髓性白血病的基因组变异分析:易感与驱动性改变
在德国CML-PAED-II注册研究2007年1月至2023年9月入组的231例儿童慢性髓性白血病患者中,25例(11%)诊断为急变期。对19例有足够生物材料的急变期患者进行全基因组测序、深度靶向测序和细胞遗传学分析,发现拷贝数变异比单核苷酸变异更常见,且继发性急变期比初诊急变期更普遍;9例(47%)携带DNA损伤反应(DDR)基因的致病性胚系或体细胞变异,而慢性期对照队列19例中仅1例(5%)携带致病性DDR胚系变异。
要点
- 231例儿童CML中25例(11%)为急变期,19例接受全基因组测序等分析。
- 拷贝数变异比单核苷酸变异更常见,且继发性急变期比初诊急变期更普遍。
- 9例(47%)携带DDR基因致病性变异,提示遗传易感性可能涉及患者及家族。
核心结论
- 本研究为儿童急变期慢性髓性白血病提供了新的发病机制见解。
- 致病性DDR相关胚系变异的发现提示遗传易感性,可能对患者和家族的癌症治疗与监测有潜在意义。
研究设计与样本
- 德国CML-PAED-II注册研究2007年1月至2023年9月入组231例儿童患者,其中25例(11%)诊断为急变期。
- 对19例有足够生物材料的急变期患者(初诊急变期11例,继发性急变期8例)进行全基因组测序、深度靶向测序和细胞遗传学分析。
- 另设19例儿童慢性期CML患者作为比较队列。
主要发现
- 拷贝数变异比单核苷酸变异更常见,且继发性急变期比初诊急变期更普遍。
- 复发性致病性体细胞单核苷酸变异见于ABL1(5例,24%)、RUNX1(2例,12%)和ASXL1(2例,12%)。
- 9例(47%)携带ATM、CHEK2、FANCM、HERC2、NBN、RAD54B、RECQL4、SETD2或TP63等DDR基因的致病性胚系(8例)或体细胞(1例)变异。
- 在19例儿童慢性期CML比较队列中,仅1例(5%)携带致病性DDR胚系变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Paediatric blast-phase chronic myeloid leukaemia (CML-BP) is a rare and serious condition. Of 231 paediatric patients enrolled in the German CML-PAED-II registry between January 2007 and September 2023, 25 individuals (11%) were diagnosed with CML-BP. To identify genetic variants associated with early onset and disease transformation, we performed whole genome sequencing (WGS), deep targeted sequencing and cytogenetic analyses in 19 cases with de novo (n = 11) or secondary (n = 8) CML-BP and sufficient available biomaterial. Copy number variants (CNVs) were more frequent than single nucleotide variants (SNVs) and more prevalent in secondary than in de novo CML-BP. Recurrent pathogenic somatic SNVs were observed in ABL1 (n = 5, 24%), RUNX1 (n = 2, 12%) and ASXL1 (n = 2, 12%). Nine patients (47%) carried pathogenic germline (n = 8) or somatic (n = 1) variants in either of the genes ATM, CHEK2, FANCM, HERC2, NBN, RAD54B, RECQL4, SETD2 or TP63 belonging to the DNA damage response (DDR). Within a comparison cohort of 19 patients with chronic phase paediatric CML, only one individual (5%) exhibited a pathogenic DDR germline variant. Our study provides novel pathogenetic insights into paediatric CML-BP. The identification of pathogenic DDR-associated germline variants suggests a genetic predisposition with potential implications for patients and families concerning cancer treatment and surveillance.
引用
- Behrens YL, Reinkens T, Hofmann W, et al. Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations. Br J Haematol. 2025. PMID: 40344211. doi:10.1111/bjh.20133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。